Related Experiment Video
Updated: Sep 9, 2025

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
Published on: March 1, 2019
Identification and Structural Characterization of Viroporins from Deadly Hemorrhagic Viruses
Hiya Lahiri1,2, Kingshuk Basu2, Isaiah T Arkin1,2
1Department of Biological Chemistry, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Edmond J. Safra Campus, Jerusalem 9190400, Israel.
Insights
Researchers identified a viroporin in Crimean-Congo hemorrhagic fever virus (CCHF-V) using genetic assays. This finding offers potential for developing new treatments against CCHF-V, unlike Ebola virus where no viroporin was found.
Area of Science:
- Virology
- Molecular Biology
- Drug Discovery
Background:
- Crimean-Congo hemorrhagic fever virus (CCHF-V) and Ebola virus are Risk Group 4 pathogens causing severe hemorrhagic fever outbreaks.
- Limited effective treatments exist for these viral diseases, necessitating novel therapeutic strategies.
- Viral ion channels, or viroporins, are potential drug targets for antiviral development.
Purpose of the Study:
- To identify and characterize viroporin candidates in CCHF-V and Ebola virus genomes.
- To model the structures of potential viroporins to facilitate drug discovery efforts.
- To explore novel therapeutic avenues against CCHF-V and Ebola virus infections.
Main Methods:
- Utilized bacteria-based genetic assays to screen for viroporin activity.
- Examined two candidate viroporins from CCHF-V and Ebola virus.
- Modeled the proposed structures of identified viral ion channels.
Main Results:
- CCHF-V glycoprotein (gp) demonstrated significant ion channel activity, consistent with known viroporins.
- No viroporin candidate was identified in the Ebola virus genome using the employed experimental approach.
- Structural modeling was performed to aid in understanding the function of CCHF-V viroporin.
Conclusions:
- The CCHF-V glycoprotein functions as a viroporin, presenting a viable target for antiviral drug development.
- The absence of a detectable viroporin in Ebola virus under these conditions warrants further investigation.
- This research opens new avenues for targeted therapies against CCHF-V, a significant public health threat.
Abstract:
Crimean-Congo hemorrhagic fever virus (CCHF-V) and Ebola virus are lethal pathogens that cause widespread outbreaks of hemorrhagic fever. Both diseases can be transmitted through contact with the bodily fluids of infected individuals, but as an arbovirus, CCHF-V is primarily transmitted through tick bites. Both of these viruses are classified as Risk Group 4 due to the appreciable health threat they pose. To date, there are few effective treatments available to combat these deadly hemorrhagic fevers. Consequently, identifying and characterizing ion channels (viroporins) encoded in the viral genomes may lead to potential targeted drug development. Therefore, using bacteria-based genetic assays, two viroporin candidates from CCHF-V and Ebola have been examined, and their proposed structures have been modeled to aid in further drug discovery. The results indicate that CCHF-V-gp exhibits channel activity, which is indistinguishable from established viroporins found in other viruses. In contrast, our experimental approach was unable to uncover a viroporin candidate in the Ebola virus.
More Related Videos
Related Concept Videos
Viral Structure
Introduction to Virus
Size and Structure of Viral Genomes
Subviral Agents
What are Viruses?
Viruses with RNA Genomes

